AACR Journals

About Personal Genome Diagnostics

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequencing and liquid biopsy technologies.

Contacts

PGDx Corporate:

Megan Bailey
Vice President, Marketing
520-820-8710
mbailey@pgdx.com

W20 Group:

Peter Duckler
Director, Media
773-343-3068
pduckler@w2ogroup.com
Media Inquiries
+1-443.602.8833